FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109449062> ?p ?o ?g. }

• W2109449062 endingPage "3005" @default.
• W2109449062 startingPage "2998" @default.
• W2109449062 abstract "It has been proposed that Cyclooxygenase (COX)-2 inhibitors may be able to enhance the effects of chemotherapeutic or radiation treatment; however, currently few studies have been reported that define the radiation-enhancing effect of COX-2 inhibitors. We conducted in vitro radiation survival experiments using rat intestinal epithelial cells which were stably transfected with COX-2 cDNA in the sense (RIE-S) and antisense (RIE-AS) orientations to investigate the potential radiosensitizing effect of the selective COX-2 inhibitor, NS-398. Apoptosis was measured using 7-aminoactinomycin-D with flow cytometry to investigate underlying mechanisms for the effect of NS-398 on radiosensitivity. The same experiments were repeated with NCI-H460 human lung cancer cells, which express COX-2 constitutively, and HCT-116 human colon cancer cells, which lack COX-2 expression. In vivo tumor growth delay assays were also performed with tumors formed by H460 and HCT-116 cells. No difference was observed in the intrinsic radiation sensitivity of RIE-S and RIE-AS cells exposed to radiation alone. However, 150-400 microM of NS-398 enhanced radiosensitivity in a concentration-dependent manner in RIE-S cells with dose enhancement ratios of 1.2-1.9 at a surviving fraction of 0.25. However, this effect was not shown in RIE-AS cells. NS-398 enhanced radiosensitivity in H460 cells with a dose enhancement ratio of 1.8 but protected HCT-116 cells from the effects of radiation. Radiation-induced apoptosis was enhanced by NS-398 in RIE-S and H460 cells but not in RIE-AS and HCT-116 cells. Additionally, this radiation-enhancing effect in RIE-S cells seemed to be attributable to some mechanisms other than the reversal of radioresistance induced by COX-2. NS-398 (36 mg/kg) enhanced the effect of radiation on H460 tumors in vivo by an enhancement factor of 2.5; however, it did not enhance the radiosensitivity of HCT-116 tumors (enhancement factor = 1.04). These in vitro and in vivo results suggest that selective COX-2 inhibitors enhance the effect of radiation on tumors that express COX-2 but not on COX-2-lacking tumors. This effect may be attributable to enhancement of radiation-induced apoptosis. Thus, selective COX-2 inhibitors may have potential as radiosensitizers for treatment of human cancers." @default.
• W2109449062 created "2016-06-24" @default.
• W2109449062 creator A5019651118 @default.
• W2109449062 creator A5057356667 @default.
• W2109449062 creator A5066993165 @default.
• W2109449062 creator A5075677192 @default.
• W2109449062 creator A5081429171 @default.
• W2109449062 creator A5087827655 @default.
• W2109449062 creator A5090373031 @default.
• W2109449062 date "2001-10-01" @default.
• W2109449062 modified "2023-09-23" @default.
• W2109449062 title "A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2." @default.
• W2109449062 cites W110134706 @default.
• W2109449062 cites W1490667530 @default.
• W2109449062 cites W1496912415 @default.
• W2109449062 cites W1506887248 @default.
• W2109449062 cites W1521161473 @default.
• W2109449062 cites W1685016018 @default.
• W2109449062 cites W1800050944 @default.
• W2109449062 cites W1955690499 @default.
• W2109449062 cites W1960701671 @default.
• W2109449062 cites W1971967721 @default.
• W2109449062 cites W1998394615 @default.
• W2109449062 cites W2008498104 @default.
• W2109449062 cites W2009132110 @default.
• W2109449062 cites W2034679499 @default.
• W2109449062 cites W2043707891 @default.
• W2109449062 cites W2049169085 @default.
• W2109449062 cites W2051090019 @default.
• W2109449062 cites W2053252255 @default.
• W2109449062 cites W2058118671 @default.
• W2109449062 cites W2074738823 @default.
• W2109449062 cites W2085552591 @default.
• W2109449062 cites W2087224686 @default.
• W2109449062 cites W2090535621 @default.
• W2109449062 cites W2095440868 @default.
• W2109449062 cites W2107359522 @default.
• W2109449062 cites W2107833029 @default.
• W2109449062 cites W2117580825 @default.
• W2109449062 cites W2120850551 @default.
• W2109449062 cites W2127558096 @default.
• W2109449062 cites W2129733741 @default.
• W2109449062 cites W2132069490 @default.
• W2109449062 cites W2133592787 @default.
• W2109449062 cites W2136501106 @default.
• W2109449062 cites W2136789423 @default.
• W2109449062 cites W2137956025 @default.
• W2109449062 cites W2143600529 @default.
• W2109449062 cites W2144534445 @default.
• W2109449062 cites W2148907720 @default.
• W2109449062 cites W2155127143 @default.
• W2109449062 cites W2156470937 @default.
• W2109449062 cites W2161602193 @default.
• W2109449062 cites W2170720478 @default.
• W2109449062 cites W2180159320 @default.
• W2109449062 cites W2315576646 @default.
• W2109449062 cites W2331264852 @default.
• W2109449062 cites W2430212860 @default.
• W2109449062 cites W3049027600 @default.
• W2109449062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11595687" @default.
• W2109449062 hasPublicationYear "2001" @default.
• W2109449062 type Work @default.
• W2109449062 sameAs 2109449062 @default.
• W2109449062 citedByCount "65" @default.
• W2109449062 countsByYear W21094490622012 @default.
• W2109449062 countsByYear W21094490622013 @default.
• W2109449062 countsByYear W21094490622014 @default.
• W2109449062 countsByYear W21094490622017 @default.
• W2109449062 countsByYear W21094490622019 @default.
• W2109449062 countsByYear W21094490622020 @default.
• W2109449062 crossrefType "journal-article" @default.
• W2109449062 hasAuthorship W2109449062A5019651118 @default.
• W2109449062 hasAuthorship W2109449062A5057356667 @default.
• W2109449062 hasAuthorship W2109449062A5066993165 @default.
• W2109449062 hasAuthorship W2109449062A5075677192 @default.
• W2109449062 hasAuthorship W2109449062A5081429171 @default.
• W2109449062 hasAuthorship W2109449062A5087827655 @default.
• W2109449062 hasAuthorship W2109449062A5090373031 @default.
• W2109449062 hasConcept C111337013 @default.
• W2109449062 hasConcept C121332964 @default.
• W2109449062 hasConcept C126322002 @default.
• W2109449062 hasConcept C150903083 @default.
• W2109449062 hasConcept C153911025 @default.
• W2109449062 hasConcept C181199279 @default.
• W2109449062 hasConcept C185544564 @default.
• W2109449062 hasConcept C185592680 @default.
• W2109449062 hasConcept C190283241 @default.
• W2109449062 hasConcept C202751555 @default.
• W2109449062 hasConcept C206684579 @default.
• W2109449062 hasConcept C207001950 @default.
• W2109449062 hasConcept C26114605 @default.
• W2109449062 hasConcept C2779689624 @default.
• W2109449062 hasConcept C502942594 @default.
• W2109449062 hasConcept C509974204 @default.
• W2109449062 hasConcept C54009773 @default.
• W2109449062 hasConcept C54355233 @default.
• W2109449062 hasConcept C553184892 @default.
• W2109449062 hasConcept C55493867 @default.

• next